The Patent Finder

Signal Coordinating Therapy, Inc.

Also on record
Records under this name other than patents Signal Coordinating Therapy, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Signal Coordinating Therapy, Inc.

PatentTitleStatus Expires Confidence
US 6,977,169Methods and compositions for treating neoplasms
Term ended
Term ended Apr 5, 2021 · From the USPTO record
Term endedTerm ended Apr 5, 2021From the USPTO record
US 7,842,314Methods and compositions for treating neoplasms
Lapsed on the fee record
Ended Nov 30, 2018 · From the USPTO record
Lapsed on the fee recordEnded Nov 30, 2018From the USPTO record
US 4,521,405Methods and materials for treatment of disease states involving immunological factors
Term ended
Term ended no later than Jun 4, 2005 · Low confidence
Term endedTerm ended no later than Jun 4, 2005Low confidence
US 4,705,685Methods and materials for treatment of disease states involving immunological factors
Term ended
Term ended no later than Nov 10, 2007 · Low confidence
Term endedTerm ended no later than Nov 10, 2007Low confidence
US 5,558,863Method for treatment of herpes virus infections
Formerly held
Term ended
Term ended no later than Sep 24, 2016 · Low confidence
Term endedTerm ended no later than Sep 24, 2016Low confidence
US 5,645,997Assay and treatment for demyelinating diseases such as multiple sclerosis, related hybridomas and monoclonal antibodies
Term ended
Term ended no later than Jul 8, 2017 · Low confidence
Term endedTerm ended no later than Jul 8, 2017Low confidence
US 5,736,133Method and composition for the treatment of a individual infected with an immunodeficiency virus
Formerly held
Term ended
Term ended no later than Apr 7, 2018 · Low confidence
Term endedTerm ended no later than Apr 7, 2018Low confidence
US 5,804,188Method and composition for treatment of disorders involving immunological dysfunction
Formerly held
Term ended
Term ended no later than Sep 8, 2018 · Low confidence
Term endedTerm ended no later than Sep 8, 2018Low confidence
US 5,846,532Method and composition for the treatment of disorders involving immunological dysfunction
Formerly held
Term ended
Term ended no later than Dec 8, 2018 · Low confidence
Term endedTerm ended no later than Dec 8, 2018Low confidence
US 5,883,227Multiple sclerosis associated polypeptide
Term ended
Term ended no later than Mar 16, 2019 · Low confidence
Term endedTerm ended no later than Mar 16, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited